{
    "organizations": [],
    "uuid": "3a3aac04d53739e0dd3b950a6bdd68af66f42266",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-recro-pharma-reports-q1-loss-per-s/brief-recro-pharma-reports-q1-loss-per-share-of-0-65-idUSASC0A0WV",
    "ord_in_thread": 0,
    "title": "BRIEF-Recro Pharma Reports Q1 Loss Per Share Of $0.65",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Recro Pharma Inc:\n* RECRO PHARMA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS\n* Q1 LOSS PER SHARE $0.65 * Q1 REVENUE $19.5 MILLION VERSUS I/B/E/S VIEW $17.7 MILLION\n* Q1 EARNINGS PER SHARE VIEW $-0.70 â€” THOMSON REUTERS I/B/E/S\n* AS OF MARCH 31, 2018, RECRO HAD CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS OF $51.3 MILLION\n* REAFFIRMS ITS 2018 CDMO GUIDANCE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-09T19:21:00.000+03:00",
    "crawled": "2018-05-10T17:36:33.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "recro",
        "pharma",
        "inc",
        "recro",
        "pharma",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "revenue",
        "million",
        "versus",
        "view",
        "million",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "march",
        "recro",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "million",
        "reaffirms",
        "cdmo",
        "guidance",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}